Treatments like stem cell therapy and platelet-rich plasma therapy once were cost-prohibitive for the average pet owner, but now, because of advances in cell processing and methods of stem cell harvest and storage in younger animals at the time of spay/neuter, treatments are much more feasible.
Treatments like stem cell therapy and platelet-rich plasma therapy once were cost-prohibitive for the average pet owner, but now, because of advances in cell processing and methods of stem cell harvest and storage in younger animals at the time of spay/neuter, treatments are much more feasible.
The safety of these methods is very high, because we use information stored in the pets own cells to trigger healing and tissue regeneration.
PRP (platelet-rich plasma) is a treatment that can offer great benefits to pets suffering from a variety of conditions, including joint and muscle injuries. Stem cell therapy is another treatment that is used in combination with PRP for more effective and long-term treatment of degenerative diseases.
In my clinics, PRP treatments are performed frequently and yield excellent results for dogs and cats, most often with one to two joint injuries, including ligament injuries to knee or stifle. The treatment has shown effectiveness in reducing pain, arthritis formation, and improving patients joint stability, bringing about healing and full return of function. Most patients who receive PRP with Prolotherapy do not require surgical stabilization of injured joints.
Stem cell with PRP therapy is done for more extensive and advanced degenerative conditions, also yielding great results for pets. When pets are suffering with arthritis in numerous joints, the spinal column or experiencing degenerative spinal cord disorders, pets and owners can see stabilization and improvement over three to four months.
Owners often report additional benefits involving the immune system, chronic Lyme disease, and allergies.
What exactly are stem cell and PRP?
Stem cells are cells from which all cells begin, which are able to become any tissue in the body. They are plentiful in developing fetuses of all mammals. They have the ability to reproduce repeatedly and can help regenerate injured tissues and bring about health, renewal and repair in the adult body.
When an animal or human body is developing, prior to birth, stem cells are plentiful, but as we age, they diminish in numbers.
Stem cells have some characteristics that make them helpful in regenerative medicine, including the ability to self-renew, and to differentiate (turn themselves into the type of cells that are needed for healing injured or damaged tissues).
They can be found in the adult body in many different tissues, including bone marrow and fat cells.
In veterinary medicine, multiple companies have advocated and produced methods of extracting stem cells from pets fat cells. The early unique and patented systems of stem cell harvest/activation, which were originally touted as effective in the early years of providing therapy, did not yield highly consistent and effective results in the treatment of aging disease. Most patients treated with stem cells were those suffering from degenerative conditions, such as arthritis and spinal degenerative conditions.
When pets and humans age, the number of active stem cells diminishes, so newer methods have been developed in veterinary medicine that use the pets own tissues, avoid the use of bone marrow (harvesting bone marrow is painful for the pet), and are minimally invasive.
When an older pet has degenerative processes going on in multiple joints, the pets fat cells can be extracted during a simple surgical procedure. Some of the cells are prepared for injection later the same day, while some are sent into storage or banking for future use.
In my office, processing with equipment in-house produces stem cells within four hours of being extracted. They are activated for injection on the same day into injured tissues, including joints.
During the treatment process, we combine stem cells with factors extracted from the bloods platelets, which are isolated in a separate, sterile process. The injection also involves adding stem cells and PRP to an intravenous infusion, so the entire body can be positively impacted.
Clients often report being able to take pets off pain and allergy medications, after a successful stem-cell treatment.
There are patients who should not receive their own stem cells. These include cancer patients. When pets have cancer cells being produced in their bodies, extracting stem cells for infusion and injection can actually accelerate the spread of neoplasia.
To prevent this, older pets are carefully screened with cancer risk assessment testing, including extensive blood work, prior to scheduling the procedure.
Owners of younger pets can improve their pets stem cell yield by having their pets stem cells collected when the pet is spayed or neutered and then take advantage of stem cell banking or storage. The great advantage we have seen is that stem cell harvests can yield much higher numbers of treatments than harvests produce when a pet is 8 to 15 years old. Additionally, in the older pet, the stem-cell collection process can be skipped when the cells are needed. We would simply order the cells to be delivered for the date of treatment, and a pet would only need a light sedative for injection into affected spinal or joint areas.
To learn more about stem cell and PRP treatments, as effective therapies and alternatives to surgeries, visit http://medivetbiologics.com.
Dr. Cynthia Maro is a veterinarian at the Ellwood Animal Hospital in Ellwood City and the Chippewa Animal Hospital in Chippewa Township. She writes a biweekly column on pet care and health issues. If you have a topic youd like to have addressed, email ellwoodvet@msn.com.
See the original post here:
Dr. Maro: Hope for aging, injured pets through stem cell, plasma therapies - Ellwood City Ledger
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments